ApoE基因多态和金属及其与认知功能的相互作用
Zeyan Ye1, Dechan Tan2, Tingyu Luo1
1Department of Environmental Health and Occupational Medicine, School of Public Health, Guilin Medical University, The Guangxi Key Laboratory of Environmental Exposomics and Entire Lifecycle Heath, Zhiyuan Road No.1, Guilin, Guangxi province, 541199, PR China.
BMC medical genomics
|August 29, 2023
概括
这项研究发现,特定的ApoE基因变异 (rs7412,rs7259620,rs405509) 与老年人认知障碍有关. 此外,血中的水平与这些基因变异相互作用,增加认知能力下降的风险.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 环境健康 环境健康
背景情况:
- 老年人的认知障碍是一个日益严重的公共卫生问题.
- 遗传因素的作用,如Apolipoprotein E (ApoE) 基因多态性,在认知衰退中越来越被认可.
- 环境因素,包括等离子体金属元素,也可能影响认知健康.
研究的目的:
- 为了研究血金属元素,ApoE基因多态性和老年人群的认知功能之间的关联.
- 探索与认知障碍有关的等离子体金属元素和ApoE基因变异之间的相互作用.
主要方法:
- 通过使用标准检查和问卷,对911名老年人的认知功能进行了评估.
- 测量了等离子体金属元素度,并对ApoE基因变异 (rs7412, rs7259620, rs405509) 进行了单核酸多态 (SNP) 类型化.
- 使用二进制逻辑回归分析来确定影响认知状态和基因环境相互作用的因素.
主要成果:
- 特定的ApoE基因型 (rs7412-TT,rs7259620-AA,rs405509-GG) 与认知障碍的风险增加显著相关.
- 在认知障碍和对照组之间,铁 (Fe),铜 (Cu) 和 (Rb) 的血度有显著差异.
- 较低度 (Q1) 的血 (Cd) 显示出保护作用,而较高度与ApoE变体 (rs7259620,rs405509) 相互作用,显著提高认知障碍的风险.
结论:
- 在位点rs7412,rs7259620和rs405509的ApoE基因多态性与老年人的认知障碍有关.
- 血中含量与ApoE基因变异 (rs7259620,rs405509) 之间存在相互作用,加剧了这一群体认知能力下降的风险.
相关概念视频
Human Genetics
611
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
611
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
151
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
151
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Background and Environment Affect Phenotype
6.6K
Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
6.6K
Factors Affecting Drug Biotransformation: Biological
177
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
177


